← FDA Drug Approvals (Drugs@FDA)
ANDA213235
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2025-07-21
Drug application
- FDA Application #
ANDA213235
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- —
- Generic name
- —
- Active ingredients
- —
- Dosage form
- —
- Route
- —
- Marketing status
- —
- Sponsor
- GLENMARK PHARMS LTD
- First approval
- 2025-07-21
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown